Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.24.1.1.u2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022 $ 104,520   $ 270,129 $ (47) $ (165,562)
Beginning balance, Shares at Dec. 31, 2022   29,445,134      
Stock-based compensation 2,480   2,480    
Net unrealized losses on available-for-sale securities 47     47  
Issuance of common stock in connection with exercise of stock options 458   458    
Issuance of common stock in connection with exercise of stock options, Shares   84,264      
Issuance of common stock upon exercise of pre-funded warrants   1,811,591      
Net Income (Loss) (15,854)       (15,854)
Ending balance at Mar. 31, 2023 91,651   273,067 (0) (181,416)
Ending balance, Shares at Mar. 31, 2023   31,340,989      
Beginning balance at Dec. 31, 2022 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022   29,445,134      
Ending balance at Dec. 31, 2023 $ 236,198   469,396 39 (233,237)
Ending balance, Shares at Dec. 31, 2023 47,823,232 47,823,232      
Stock-based compensation $ 3,791   3,791    
Common stock issuance 5,746   5,746    
Common stock issuance, Shares   258,070      
Net unrealized losses on available-for-sale securities (77)     (77)  
Issuance of common stock in connection with exercise of stock options 1,109   1,109    
Issuance of common stock in connection with exercise of stock options, Shares   167,813      
Net Income (Loss) (25,047)       (25,047)
Ending balance at Mar. 31, 2024 $ 221,720   $ 480,042 $ (38) $ (258,284)
Ending balance, Shares at Mar. 31, 2024 48,249,115 48,249,115